IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION

  • STATUS
    Recruiting
  • End date
    Nov 15, 2026
  • participants needed
    3000
  • sponsor
    Johann Wolfgang Goethe University Hospital
Send
Updated on 5 August 2020
See if I qualify
heart disease
MRI
covid-19

Summary

Magnetic properties of myocardial tissue change in the presence of disease. This is detectable in the change of rate of magnetic relaxation, and measurable by T1 and T2 mapping using cardiovascular magnetic resonance (CMR). These markers provide novel quantifiable imaging measures for myocardial tissue characterisation. Despite similar principles the measurements differ considerably between different sequences, vendors and field strengths, yielding a necessity to establish robust sequence-specific normal ranges, diagnostic accuracy and prognostic relationships in apparently healthy subjects with no known heart disease. A further unknown relates to separation between healthy myocardium and the subclinical disease in several groups of patients with suspected cardiac involvement. Examples include patients with systemic inflammatory conditions, as well as patients with a recent COVID-19 infection.

Details
Condition Heart failure, Heart failure, Heart disease, Heart disease, Cardiomyopathy, Cardiomyopathy, Myocarditis, Myocardial Fibrosis
Age 18years - 100years
Treatment CMR with T1 and T2 mapping
Clinical Study IdentifierNCT04444128
SponsorJohann Wolfgang Goethe University Hospital
Last Modified on5 August 2020

Eligibility

 Yes No Not Sure

Inclusion Criteria

Able to provide informed consent
18 years of age and over
Absence of a valid clinical indication for CMR, including active cardiac symptoms and/or known or clinically relevant cardiac disease

Exclusion Criteria

accepted contraindications for a contrast-enhanced CMR study (in line with MRI safety and SmPC for contrast agent)
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

heart disease
MRI
covid-19

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.